determin
spectrum
pathogen
caus
acut
febril
respiratori
ill
human
immunodefici
viru
hiv
infect
adult
reanalyz
data
prospect
surveil
studi
involv
outpati
receiv
highli
activ
antiretrovir
therapi
nasopharyng
sampl
test
respiratori
virus
multiplex
reversetranscriptas
polymeras
chain
reaction
pcr
atyp
bacteria
pcr
sputum
cultur
serolog
test
perform
virus
account
infect
influenza
case
human
metapneumoviru
infect
case
common
associ
bronchospasm
bacteri
infect
occur
patient
concurr
viral
infect
patient
receiv
antibiot
rapid
test
identifi
specif
viral
pathogen
could
aid
patient
manag
reduc
unnecessari
antibiot
exposur
defect
humor
cellular
immun
associ
human
immunodefici
viru
hiv
infect
potenti
alter
cours
sever
common
viral
infect
although
highli
activ
antiretrovir
therapi
haart
may
partial
restor
defici
hivinfect
person
may
remain
increas
risk
morbid
respiratori
ill
especi
abil
gener
antigenspecif
respons
remain
impair
high
preval
smoke
chronic
lung
diseas
among
individu
may
predispos
hivinfect
patient
respiratori
tract
infect
despit
potenti
public
health
impact
viral
infect
popul
virtual
inform
caus
risk
factor
outcom
respiratori
infect
haart
era
sever
respiratori
virus
recent
discov
includ
human
metapneumoviru
hmpv
coronavirus
hmpv
particular
import
caus
sever
respiratori
ill
particularli
children
elderli
individu
immunocompromis
individu
studi
examin
role
hivinfect
adult
hmpv
like
respiratori
syncyti
viru
rsv
may
potenti
import
given
predilect
caus
diseas
immunocompromis
host
develop
new
technolog
polymeras
chain
reaction
pcr
coupl
microarray
hybrid
allow
us
reanalyz
specimen
data
collect
prospect
surveil
studi
involv
hivinfect
outpati
consult
health
care
servic
fever
respiratori
symptom
haart
era
furthermor
extend
studi
search
common
atyp
bacteri
pathogensmycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophilaand
convent
bacteria
sputum
aim
identifi
full
rang
pathogen
respons
respiratori
tract
infect
hivinfect
outpati
method
consecut
patient
present
febril
respiratori
syndrom
novemb
april
recruit
larg
universitybas
clinic
montreal
chest
hospit
mcgill
univers
health
centr
montreal
canada
serv
hivinfect
adult
protocol
approv
research
ethic
board
respiratori
infect
defin
document
temperatur
associ
follow
clinic
symptom
cough
tachypnea
dyspnea
wheez
stridor
rhinorrhea
sore
throat
myalgia
fifti
seven
patient
screen
enrol
five
patient
inelig
undocu
temperatur
refus
nasopharyng
aspir
complet
followup
visit
inform
consent
demograph
clinic
data
vital
sign
record
addit
investig
chest
sinu
radiograph
complet
blood
count
blood
cultur
perform
discret
treat
physician
acut
serum
sampl
collect
initi
consult
inform
durat
outcom
episod
convalesc
serum
sampl
obtain
week
later
nasopharyng
aspir
use
collect
respiratori
specimen
novemb
april
combin
nasal
throat
swab
use
describ
origin
studi
found
similar
agreement
nasal
pharyng
aspir
swab
pcr
inhibitori
substanc
detect
clinic
sampl
sampl
store
day
ship
central
laboratori
aliquot
store
analys
end
studi
respiratori
sampl
origin
test
influenza
b
viru
rsv
hmpv
use
inhous
realtim
multiplex
reversetranscriptas
pcr
assay
describ
elsewher
use
aliquot
origin
sampl
store
frozen
test
adenovirus
group
b
c
e
rhinoviru
b
influenza
b
viru
hmpv
b
rsv
b
parainfluenzavirus
type
coronavirus
enterovirus
ad
multiplex
pcr
follow
primer
extens
microarray
hybrid
integr
molecular
diagnost
devic
infin
analyz
autogenom
comparison
sensit
gene
target
assay
shown
tabl
pair
acut
convalesc
serum
sampl
test
standard
complement
fixat
assay
influenza
b
viru
rsv
parainfluenzavirus
adenovirus
increas
titer
consid
diagnost
acut
infect
nasopharyng
sampl
test
presenc
rrna
gene
pneumonia
c
pneumonia
l
pneumophila
also
sputum
sampl
induc
taken
individu
product
cough
sent
local
microbiolog
laboratori
bacteri
cultur
antibiot
suscept
baselin
characterist
compar
patient
differ
infect
use
x
fisher
exact
test
proport
wilcoxonmannwhitney
u
test
continu
variabl
data
analyz
use
sa
softwar
version
sa
institut
result
fifti
patient
met
studi
criteria
consent
particip
median
cell
count
cellsml
rang
cellsml
median
hiv
rna
level
copiesml
rang
cellsml
particip
receiv
haart
subject
receiv
haart
either
undergo
treatment
interrupt
patient
cell
count
cellsml
patient
fortynin
patient
suffici
respiratori
specimen
pcr
test
identif
pathogen
made
patient
use
method
includ
isol
viru
concomit
viral
bacteri
isol
isol
bacteria
thu
viral
infect
contributori
patient
use
pcr
detect
addit
viral
infect
compar
number
infect
detect
inhous
pcr
increas
diagnost
yield
compar
previou
analys
previous
identifi
influenza
viru
infect
case
influenza
b
viru
infect
detect
new
assay
addit
case
influenza
b
viru
infect
found
bring
total
number
influenza
infect
viral
load
addit
case
low
high
cycl
threshold
number
case
influenza
detect
new
assay
patient
also
serolog
test
result
posit
influenza
viru
suggest
truli
posit
result
virus
detect
hmpv
patient
hmpv
b
patient
includ
concomit
influenza
b
viru
infect
rsv
patient
patient
patient
coronaviru
patient
concomit
influenza
viru
infect
previous
case
hmpv
rsv
coronaviru
infect
detect
case
detect
octob
april
year
isol
case
pneumonia
c
pneumonia
l
pneumophila
infect
detect
respiratori
specimen
one
patient
infect
detect
multiplex
pcr
serolog
test
also
test
result
posit
c
pneumonai
pneumonia
anoth
patient
influenza
b
viru
detect
multiplex
test
also
pneumonia
infect
four
patient
sputum
cultur
document
bacteri
pathogen
streptococcu
pneumonia
includ
patient
bacteremia
one
hmpv
isol
anoth
influenza
viru
isol
neisseria
meningitidi
clinic
diagnosi
pneumonia
normal
chest
radiograph
find
demograph
clinic
characterist
studi
popul
group
pathogen
isol
shown
tabl
note
individu
influenza
infect
undiagnos
infect
lower
cell
count
individu
etiolog
p
p
detail
relat
case
influenza
previous
publish
detect
addit
case
alter
previou
find
focus
characterist
patient
hmpv
infect
second
isol
pathogen
differenti
influenza
patient
hmpv
infect
influenza
receiv
haart
howev
patient
hmpv
infect
higher
median
cell
count
vs
cellsul
p
p
patient
receiv
influenza
vaccin
compar
influenza
patient
hmpv
infect
like
other
histori
asthma
vs
distinguish
clinic
characterist
hmpv
infect
associ
selfreport
wheez
vs
confirm
p
p
physic
examin
vs
patient
p
p
isol
hmpv
infect
pneumonia
diagnos
basi
chest
radiograph
eightythre
percent
patient
hmpv
infect
receiv
antibiot
therapi
time
rate
similar
influenza
despit
common
clinic
diagnos
common
cold
flulik
ill
none
patient
receiv
diagnosi
hmpv
infect
requir
hospit
compar
patient
influenza
discuss
almost
inform
exist
etiolog
respiratori
tract
infect
hivposit
outpati
haart
era
previou
studi
reveal
import
influenza
set
confirm
inclus
addit
detect
case
influenza
account
observ
respiratori
tract
ill
popul
increas
sensit
spectrum
multiplex
detect
devic
employ
expand
find
highlight
frequenc
divers
number
respiratori
tract
virus
includ
knowledg
first
time
demonstr
hmpv
import
pathogen
account
infect
hmpv
mainli
circul
concurr
influenza
b
viru
late
winter
month
publish
studi
examin
role
viral
pathogen
among
hivinfect
patient
haart
era
prospect
studi
swiss
cohort
involv
popul
much
moreadvanc
diseas
viral
pcr
test
bronchoalveolar
lavag
specimen
patient
undergo
investig
opportunist
infect
perform
unlik
patient
receiv
haart
median
cell
count
cellsul
virus
identifi
patinet
wherea
concomit
bacteri
opportunist
infect
studi
examin
role
hmpv
infect
adult
hiv
infect
previou
report
set
observ
hmpv
infect
present
nonspecif
symptom
fever
myalgia
howev
symptom
suggest
lower
respiratori
tract
involv
predomin
cough
dyspnea
wheez
vast
major
case
inde
wheez
physic
examin
distinguish
characterist
hmpv
infect
except
case
streptococc
pneumonia
bacteremia
complic
observ
howev
patient
hmpv
infect
receiv
antibiot
despit
absenc
radiograph
sign
pneumonia
suggest
presenc
lower
respiratori
tract
symptom
may
reduc
threshold
use
antibiot
unwarr
overprescript
antibiot
may
lead
unwant
advers
effect
develop
antimicrobi
resist
patient
hmpv
infect
actual
less
immunosuppress
experienc
influenza
given
wheez
predomin
find
suggest
viralmedi
inflamm
may
underpin
clinic
symptom
associ
hmpv
infect
inde
hmpv
infect
associ
airway
hyperrespons
anim
model
human
incid
asthma
increas
among
hivinfect
children
young
adult
receiv
haart
specul
may
driven
immun
reconstitut
asthma
associ
higher
cell
count
inde
larg
proport
patient
hmpv
infect
studi
asthmat
adult
asthmat
shown
display
thu
potenti
link
hmpv
asthma
individu
hiv
infect
warrant
explor
patient
hmpv
infect
also
receiv
vaccin
influenza
vaccin
arguabl
effect
individu
higher
cell
count
higher
frequenc
hmpv
could
also
attribut
compet
risk
viral
infect
influenza
effect
prevent
studi
focus
rel
small
number
outpati
fever
includ
patient
respiratori
symptom
therefor
provid
measur
incid
variou
respiratori
infect
also
exclud
may
miss
moresever
viral
bacteri
infect
particularli
individu
pneumonia
present
directli
hospit
thu
unabl
determin
etiolog
role
respiratori
virus
moresever
diseas
final
lack
hivuninfect
asymptomat
control
group
limit
abil
determin
detect
rate
respiratori
pathogen
studi
sampl
differ
gener
popul
although
respiratori
viral
ill
may
mild
natur
account
larg
proport
respiratori
tract
infect
among
hivinfect
outpati
rapid
multiplex
pcr
test
identifi
specif
viral
pathogen
could
aid
manag
case
eg
guid
specif
influenza
treatment
reduc
antibiot
exposur
may
contribut
develop
antimicrobi
resist
clearli
need
develop
effect
antivir
therapi
vaccin
hivinfect
person
would
primari
beneficiari
